Genomic technologies are generating new resources
and a tremendous wealth of data. Optimization of their
use requires coordinated efforts on the part of many institutions
to fashion the initial organizational framework. Four years
ago, Drs. Perren Cobb, Robert Danner, and Anthony Suffredini formed
the Consortium for Expression Profile Studies in Sepsis (CEPSIS)
to address the needs of critical care investigators across 18 academic
institutions interested in applying genomic technology to the study
of critical illness and injury (http://www.cia.wustl.edu/cepsis%20redirect.htm).
Four CEPSIS meetings took place, in Santa Fe, Boston, St. Louis,
and Bethesda. The consortium then evolved into the Functional
Genomics of Critical Illness and Injury Symposium, held in 2002
and 2003 at the National Institutes of Health. (A report of the
2003 meeting may be found in JAMA 2004;291:287)
These symposia provide a unique venue for investigators to
discuss the opportunities and challenges of genomic technologies
in the care of critically ill and injured patients. The symposium
series has attracted generous funding by the NIH Clinical Center,
NIGMS, NHGRI, NCI, NIAMS, NICHD, NIAID, and Office of Rare Diseases
(Office of the Director), as well as the interest
of several hundred investigators from more than 10 countries who
attended the meetings in 2002 and 2003. |